Authors:
Janssen, AML
Bosman, CB
van Duijn, W
Oostendorp-van de Ruit, MM
Kubben, FJGM
Griffioen, G
Lamers, CBHW
van Krieken, JHJM
van de Velde, CJH
Verspaget, HW
Citation: Aml. Janssen et al., Superoxide dismutases in gastric and esophageal cancer and the prognostic impact in gastric cancer, CLIN CANC R, 6(8), 2000, pp. 3183-3192
Authors:
Jaarsma, D
Haasdijk, ED
Grashorn, JAC
Hawkins, R
van Duijn, W
Verspaget, HW
London, J
Holstege, JC
Citation: D. Jaarsma et al., Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1, NEUROBIOL D, 7(6), 2000, pp. 623-643
Authors:
Wrigley, E
Verspaget, HW
Jayson, GC
McGown, AT
Citation: E. Wrigley et al., Metallothionein expression in epithelial ovarian cancer: effect of chemotherapy and prognostic significance, J CANC RES, 126(12), 2000, pp. 717-721
Authors:
Janssen, AML
van Duijn, W
Oostendorp-van de Ruit, MM
Kruidenier, L
Bosman, CB
Griffioen, G
Lamers, CBHW
van Krieken, JHJM
van de Velde, CJH
Verspaget, HW
Citation: Aml. Janssen et al., Metallothionein in human gastrointestinal cancer, J PATHOLOGY, 192(3), 2000, pp. 293-300
Authors:
Bus, PJ
Verspaget, HW
van Krieken, JHJM
de Roos, A
Keizer, HJ
Bemelman, WA
Vasen, HFA
Lamers, CBHW
Griffioen, G
Citation: Pj. Bus et al., Treatment of mesenteric desmoid tumours with the antioestrogenic agent toremifene: case histories and an overview of the literature, EUR J GASTR, 11(10), 1999, pp. 1179-1183
Authors:
Griffioen, G
Vasen, HFA
Verspaget, HW
Lamers, CBHW
Citation: G. Griffioen et al., Familial adenomatous polyposis: from bedside to bench and vice versa - A tribute to the somatic cell geneticist P. Meera Khan, CYTOG C GEN, 86(2), 1999, pp. 125-129
Authors:
Bus, PJ
Nagtegaal, ID
Verspaget, HW
Lamers, CBHW
Geldof, H
Van Krieken, JHJM
Griffioen, G
Citation: Pj. Bus et al., Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era, ALIM PHARM, 13(11), 1999, pp. 1397-1402
Citation: Ra. Van Hogezand et Hw. Verspaget, The future role of anti-tumour necrosis factor-alpha products in the treatment of Crohn's disease (vol 56, pg 299, 1998), DRUGS, 57(1), 1999, pp. 79-79